Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lisa Bax
CONTACT
Sophie Twelves
CONTACT
Lead
CCTU- Cancer Theme
With
A phase II, multi-centre, open label, randomised trial. The trial will assess the delivery, response rate, treatment compliance, efficacy and safety of encorafenib and binimetinib compared to standard adjuvant therapy in patients with BRAFV600 mutant clinically detected AJCC stage III(B/C/D) or oligometastatic stage IV Melanoma.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted